DBV Technologies to Participate in the Citizens JMP Life Sciences Conference

Châtillon, France, May 5, 2025

DBV Technologies to Participate in the Citizens JMP Life Sciences Conference

DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced Daniel Tassé, Chief Executive Officer, will participate in a fireside chat at the Citizens JMP Life Sciences Conference on Wednesday, May 7, 2025, at 11:00am ET, in New York, NY.

Read more at globenewswire.com